» Articles » PMID: 25300445

Bipolar Sealer Not Superior to Standard Electrocautery in Primary Total Hip Arthroplasty: a Meta-analysis

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2014 Oct 11
PMID 25300445
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: To assess whether bipolar sealer has advantages over standard electrocautery in primary total hip arthroplasty (THA).

Methods: All studies published through November 2013 were systematically searched in PubMed, Embase, ScienceDirect, The Cochrane Library, and other databases. Relevant journals or conference proceedings were searched manually. Only randomized controlled trials were included. Two independent reviewers identified and assessed the literature. Mean difference in blood loss and risk ratios of transfusion rates and of complication rates in the bipolar sealer group versus the standard electrocautery group were calculated. The meta-analysis was conducted using RevMan 5.1 software.

Results: Five studies were included, with a total sample size of 559 patients. The use of bipolar sealer did not significantly reduce intraoperative blood loss, hemoglobin drop, hospital stay, and operative time. There were no significant differences in need for transfusion and the incidence of infection between the study groups.

Conclusion: The available evidence suggests that the use of bipolar sealer was not superior to standard electrocautery in patients undergoing primary THA. The use of bipolar sealer is not recommended in primary THA.

Citing Articles

Perioperative Blood Management Strategies for Patients Undergoing Total Hip Arthroplasty: Where Do We Currently Stand on This Matter?.

Vrontis K, Tsinaslanidis G, Drosos G, Tzatzairis T Arch Bone Jt Surg. 2020; 8(6):646-655.

PMID: 33313343 PMC: 7718563. DOI: 10.22038/abjs.2020.45651.2249.


Is bipolar sealer superior than standard electrocautery for blood loss control after primary total knee arthroplasty: A meta-analysis.

Chen X, Yang W, Wang X Medicine (Baltimore). 2019; 98(46):e17762.

PMID: 31725616 PMC: 6867738. DOI: 10.1097/MD.0000000000017762.


Effects of tranexamic acid and bipolar sealer alone or in combination in primary total knee arthroplasty: a prospective, randomized, controlled trial.

Seviciu A, Gross I, Fathima S, Walsh S Arthroplast Today. 2017; 2(2):77-82.

PMID: 28326403 PMC: 4957169. DOI: 10.1016/j.artd.2015.12.007.


The Efficacy of Bipolar Sealer on Blood Loss in Primary Total Hip Arthroplasty: A Meta-Analysis.

Min J, Zhang Q, Li H, Li H, Guo P Medicine (Baltimore). 2016; 95(19):e3435.

PMID: 27175643 PMC: 4902485. DOI: 10.1097/MD.0000000000003435.

References
1.
Kumar A . Perioperative management of anemia: limits of blood transfusion and alternatives to it. Cleve Clin J Med. 2009; 76 Suppl 4:S112-8. DOI: 10.3949/ccjm.76.s4.18. View

2.
Toy P, KAPLAN E, McVay P, Lee S, Strauss R, Stehling L . Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group. Transfusion. 1992; 32(1):63-7. DOI: 10.1046/j.1537-2995.1992.32192116435.x. View

3.
Falez F, Meo A, Panegrossi G, Favetti F, La Cava F, Casella F . Blood loss reduction in cementless total hip replacement with fibrin spray or bipolar sealer: a randomised controlled trial on ninety five patients. Int Orthop. 2013; 37(7):1213-7. PMC: 3685660. DOI: 10.1007/s00264-013-1903-8. View

4.
Goodnough L, Monk T . Erythropoietin therapy in the perioperative setting. Clin Orthop Relat Res. 1999; (357):82-8. DOI: 10.1097/00003086-199812000-00012. View

5.
Ratcliffe C . Development and implementation of a bloodless medicine and surgery program. J Healthc Manag. 2004; 49(6):405-9. View